Form 4 for CPIX CUMBERLAND PHARMACEUTICALS INC
Accepted 2024-07-02 00:00:00 ET · period of report 2024-06-13 · accession 0001214659-24-011867 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| M | 2024-07-02 | 2024-06-13+ | CPIX | KAZIMI A J | COB, CEO, Dir, 10% | L - Small Acq | $1.52 | +454 | 5.70M | +0.0% | +$691.38 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2024-06-14 | L | A | 48 | $1.50 | 5,695,630 | D | — | — | (F1) The reported purchases occurred automatically pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 13, 2024. |
| 2 | Common | Common Stock | 2024-06-17 | L | A | 41 | $1.49 | 5,695,671 | D | — | — | (F1) The reported purchases occurred automatically pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 13, 2024. |
| 3 | Common | Common Stock | 2024-06-21 | L | A | 41 | $1.49 | 5,695,794 | D | — | — | (F1) The reported purchases occurred automatically pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 13, 2024. |
| 4 | Common | Common Stock | 2024-06-13 | L | A | 25 | $1.52 | 5,695,582 | D | — | — | (F1) The reported purchases occurred automatically pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 13, 2024. |
| 5 | Common | Common Stock | 2024-06-28 | L | A | 41 | $1.50 | 5,696,011 | D | — | — | (F1) The reported purchases occurred automatically pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 13, 2024. |
| 6 | Common | Common Stock | 2024-06-18 | L | A | 41 | $1.57 | 5,695,712 | D | — | — | (F1) The reported purchases occurred automatically pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 13, 2024. |
| 7 | Common | Common Stock | 2024-06-20 | L | A | 41 | $1.53 | 5,695,753 | D | — | — | (F1) The reported purchases occurred automatically pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 13, 2024. |
| 8 | Common | Common Stock | 2024-06-27 | L | A | 44 | $1.52 | 5,695,970 | D | — | — | (F1) The reported purchases occurred automatically pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 13, 2024. |
| 9 | Common | Common Stock | 2024-06-26 | L | A | 44 | $1.50 | 5,695,926 | D | — | — | (F1) The reported purchases occurred automatically pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 13, 2024. |
| 10 | Common | Common Stock | 2024-06-25 | L | A | 44 | $1.54 | 5,695,882 | D | — | — | (F1) The reported purchases occurred automatically pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 13, 2024. |
| 11 | Common | Common Stock | 2024-06-24 | L | A | 44 | $1.59 | 5,695,838 | D | — | — | (F1) The reported purchases occurred automatically pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 13, 2024. |